Shahad Saif Khandker, Safrin Jahan, Adiba Ayesha Khan, Begum Faijunnesa Abrittee, Rifah Nanjiba, Dewan Zubaer Islam, Ehsan Suez, Md Habibur Rahman, Farha Farahim, Talat Ali, Rahima Begum
{"title":"Global epidemiology of HIV among dialysis patients: a systematic review and meta-analysis.","authors":"Shahad Saif Khandker, Safrin Jahan, Adiba Ayesha Khan, Begum Faijunnesa Abrittee, Rifah Nanjiba, Dewan Zubaer Islam, Ehsan Suez, Md Habibur Rahman, Farha Farahim, Talat Ali, Rahima Begum","doi":"10.1007/s11255-025-04421-5","DOIUrl":null,"url":null,"abstract":"<p><p>HIV transmission and infection among dialysis patients have become a major healthcare concern and a rising threat throughout the world. Our current systematic review and meta-analysis targeted to determine the global epidemiologic state of HIV infection among dialysis patients. Three online databases: Google Scholar, PubMed, and ScienceDirect were searched for eligible studies using specific keywords. 15 studies matched our eligibility criteria and were included in the study. The worldwide pooled prevalence of HIV among dialysis patients was 0.8% (95% CI 0.4 to 1.2) with a high degree of heterogeneity (95%) among the included studies. Substantial variations in pooled prevalence were found among different continents in our subgroup analysis. Africa (21.1%, 95% CI 6.4 to 35.8) and North America (19.3%, 95% CI 0.0 to 39.8) had a higher prevalence of HIV in dialysis patients whereas in Europe (0.3%, 95% CI 0.0 to 0.6), South America (0.7%, 95% CI 0.0 to 1.6) and Asia (0.7%, 95% CI 0.0 to 1.6) the frequency was much lower. Perhaps, due to the lack of awareness and preventive knowledge, insufficient healthcare facilities and breaches in infection control protocols in dialysis centers, risky attitudes and practices immigration issues the prevalence of HIV among dialysis patients in Africa and North America enhanced as compared to that of Europe, Asia and South America. Strict adherence to HIV preventive practices, raising public awareness, and advanced healthcare systems are suggested to reduce the prevalence of HIV among dialysis patients all over the world.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"2209-2226"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-025-04421-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
HIV transmission and infection among dialysis patients have become a major healthcare concern and a rising threat throughout the world. Our current systematic review and meta-analysis targeted to determine the global epidemiologic state of HIV infection among dialysis patients. Three online databases: Google Scholar, PubMed, and ScienceDirect were searched for eligible studies using specific keywords. 15 studies matched our eligibility criteria and were included in the study. The worldwide pooled prevalence of HIV among dialysis patients was 0.8% (95% CI 0.4 to 1.2) with a high degree of heterogeneity (95%) among the included studies. Substantial variations in pooled prevalence were found among different continents in our subgroup analysis. Africa (21.1%, 95% CI 6.4 to 35.8) and North America (19.3%, 95% CI 0.0 to 39.8) had a higher prevalence of HIV in dialysis patients whereas in Europe (0.3%, 95% CI 0.0 to 0.6), South America (0.7%, 95% CI 0.0 to 1.6) and Asia (0.7%, 95% CI 0.0 to 1.6) the frequency was much lower. Perhaps, due to the lack of awareness and preventive knowledge, insufficient healthcare facilities and breaches in infection control protocols in dialysis centers, risky attitudes and practices immigration issues the prevalence of HIV among dialysis patients in Africa and North America enhanced as compared to that of Europe, Asia and South America. Strict adherence to HIV preventive practices, raising public awareness, and advanced healthcare systems are suggested to reduce the prevalence of HIV among dialysis patients all over the world.
艾滋病毒在透析患者中的传播和感染已成为一个主要的卫生保健问题,并在全世界成为一个日益严重的威胁。我们当前的系统综述和荟萃分析旨在确定透析患者中HIV感染的全球流行病学状态。三个在线数据库:b谷歌Scholar, PubMed和ScienceDirect使用特定关键词搜索符合条件的研究。15项研究符合我们的资格标准并被纳入本研究。在纳入的研究中,透析患者中HIV的全球总患病率为0.8% (95% CI 0.4 - 1.2),且存在高度的异质性(95%)。在我们的亚组分析中,不同大陆的总患病率存在显著差异。非洲(21.1%,95% CI 6.4至35.8)和北美(19.3%,95% CI 0.0至39.8)透析患者的HIV患病率较高,而欧洲(0.3%,95% CI 0.0至0.6)、南美(0.7%,95% CI 0.0至1.6)和亚洲(0.7%,95% CI 0.0至1.6)的患病率要低得多。也许,由于缺乏认识和预防知识、保健设施不足、透析中心违反感染控制协议、危险的态度和做法以及移民问题,非洲和北美透析患者中的艾滋病毒感染率高于欧洲、亚洲和南美洲。建议严格遵守艾滋病毒预防措施,提高公众意识和先进的医疗保健系统,以减少全世界透析患者中艾滋病毒的流行。
期刊介绍:
International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.